Effects of somatostatin infusion in four patients with malignant carcinoid syndrome

Am J Gastroenterol. 1983 Mar;78(3):149-51.

Abstract

Somatostatin (4 micrograms/min, cyclic form) was infused for 24 h on six occasions in four patients with carcinoid ileal tumor and multiple liver metastases. During infusion, spontaneous flushes and/or diarrhea were markedly reduced with a return to the pretreatment pattern on the next day. Urinary 5-hydroxyindole acetic acid excretion and plasma gastrin were not significantly changed, whereas plasma insulin presented the expected decrease and rebound. These results confirm that carcinoid symptoms are somatostatin-sensitive but do not provide evidence that serotonin or gastrin play a major role in inducing these symptoms.

MeSH terms

  • Aged
  • Diarrhea / drug therapy
  • Female
  • Gastrins / blood
  • Humans
  • Hydroxyindoleacetic Acid / urine
  • Insulin / blood
  • Male
  • Malignant Carcinoid Syndrome / drug therapy*
  • Malignant Carcinoid Syndrome / metabolism
  • Middle Aged
  • Skin / blood supply
  • Somatostatin / therapeutic use*

Substances

  • Gastrins
  • Insulin
  • Somatostatin
  • Hydroxyindoleacetic Acid